Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus doxycycline for moderate inflammatory papulopustular acne
IRCT20100102002954N16Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of azithromycin, doxycycline, tretinoin and ferrous sulfate in acne vulgaris (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: Acne healing speed. Started Sep 2019; status: completed.
02
Drugs
azithromycindoxycyclinetretinoinferrous sulfate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20100102002954N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002954N16.